Pharm-Olam is now Allucent. Learn More

Request a Proposal  
Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.
Understanding-COVID-19_ebook_updated-0723-FINAL-1
Adaptive Design Considerations for Early Phase Oncology Trials
By Ahmed Abufarag, Senior Project Manager
On September 30, 2021

Adaptive Design Considerations for Early Phase Oncology Trials

“Adaptive designs” in clinical research refer to study designs where certain features are left flexible on purpose, so they can...


(6 minute read)

Tags: Pharm-Olam Insights, Oncology-Hematology Disease

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.
GDPR_Checklist-cover